Genome-wide CRISPR/Cas9 screening for drug resistance in tumors

• Váldodahkkit: Zhongyan Zhang (Dahkki), Hailiang Wang (Dahkki), Qian Yan (Dahkki), Jinwei Cui (Dahkki), Yubin Chen (Dahkki), Shiye Ruan (Dahkki), Jiayu Yang (Dahkki), Zelong Wu (Dahkki), Mingqian Han (Dahkki), Shanzhou Huang (Dahkki), Qi Zhou (Dahkki), Chuanzhao Zhang (Dahkki), Baohua Hou (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2023-11-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Genome-wide clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated nuclease 9 (Cas9) screening is a simple screening method for locating loci under specific conditions, and it has been utilized in tumor drug resistance research for finding potential drug resistance-asso...